In the current competitive and dynamic market, customer demands and interests are changing continuously, and hence, risk of disruption in the supply chain is also increasing. To be successful in this scenario, supply chain of a firm should be resilient. Most of the firms realize that with a specific end goal to develop a resilient supply chain, there is a need for assessment of performance. The purpose of this paper is to discuss supply chain resilience and identify indicators which can help in increasing the performance and making a supply chain resilient. Articles published on this issue were collected and classified to draw out some meaningful information. After classification and analyses of the collected literature, seventeen performance indicators for supply chain resilience are found. A supply chain resilience framework is developed using these indicators to assist the supply chain managers to examine and withstand the disruption.

Background and Aims:This prospective, randomized, double-blind study was undertaken to establish the effect of addition of magnesium or dexmedetomidine, as an adjuvant, to epidural bupivacaine in lower limb surgeries.Materials and Methods:One hundred and twenty ASA (American Society of Anesthesiologists) class I and II patients undergoing lower limb surgeries were enrolled to receive either magnesium sulfate (Group M) or dexmedetomidine (Group D) along with epidural bupivacaine for surgical anesthesia. All the study subjects received an epidural anesthesia with 14 ml of 0.5% bupivacaine along with either MgSO4 50 mg (Group M) or dexmedetomidine 0.5 μg/kg (Group D) or saline (Group C). The onset of motor and sensory block, duration of block, hemodynamic parameters, and any adverse events were monitored.Results:Analgesia in the postoperative period was better in Group D, duration of sensory and motor blockade was significantly prolonged in Group D and incidence of sedation was more in Group D.Conclusion:Hence, addition of dexemedetomidine to epidural bupivacaine can be advantageous with respect to increased duration of motor and sensory blockade and arousable sedation.

Garden cress (Lepidium sativum L.) belonging to Cruciferae family is widely grown in India, Europe, and United States. It has been used as an important medicinal plant since the Vedic era. Its seed, oil, and powder contain signiicant amount of protein, fat, minerals, ibers, and phytochemicals, which are incorporated in many functional beverages and foods. A number of clinical trials have been conducted on rats that also support the eicacy of garden cress seeds (GCSs). The seed of garden cress was used in the fortiication of diferent food items but due to the lack of their physicochemical properties and medicinal value, the exploration of the potential of garden cress seed was limited. In the present review, we discuss the proximate chemical composition, physicochemical, medicinal properties, and the food product development with garden cress seed. The functional properties of garden cress seed stimulate us to review its diferent valuable properties and the fortiied products developed by incorporating garden cress seeds.

No abstract

No abstract